JP2024537564A5 - - Google Patents
Info
- Publication number
- JP2024537564A5 JP2024537564A5 JP2024513882A JP2024513882A JP2024537564A5 JP 2024537564 A5 JP2024537564 A5 JP 2024537564A5 JP 2024513882 A JP2024513882 A JP 2024513882A JP 2024513882 A JP2024513882 A JP 2024513882A JP 2024537564 A5 JP2024537564 A5 JP 2024537564A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- crystal form
- crystalline form
- free acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111034159.1 | 2021-09-03 | ||
| CN202111034159 | 2021-09-03 | ||
| PCT/CN2022/116768 WO2023030492A1 (zh) | 2021-09-03 | 2022-09-02 | 一种ep4拮抗剂化合物及其盐、多晶型和用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024537564A JP2024537564A (ja) | 2024-10-11 |
| JP2024537564A5 true JP2024537564A5 (enExample) | 2024-11-14 |
| JP7819298B2 JP7819298B2 (ja) | 2026-02-24 |
Family
ID=85349540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513882A Active JP7819298B2 (ja) | 2021-09-03 | 2022-09-02 | Ｅｐ４拮抗剤化合物及びその塩、結晶多形並びに使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240368088A1 (enExample) |
| EP (1) | EP4397654A4 (enExample) |
| JP (1) | JP7819298B2 (enExample) |
| KR (1) | KR102959367B1 (enExample) |
| CN (1) | CN115745892A (enExample) |
| CA (1) | CA3230557A1 (enExample) |
| TW (1) | TW202328073A (enExample) |
| WO (1) | WO2023030492A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2533026T3 (es) | 2010-06-03 | 2015-04-07 | Bayer Intellectual Property Gmbh | N-[(het)arilalquil)]pirazol (tio)carboxamidas y sus análogos heterosustituidos |
| EP3061751A1 (en) * | 2010-09-21 | 2016-08-31 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition |
| WO2015179615A1 (en) * | 2014-05-23 | 2015-11-26 | Eisai R&D Management Co., Ltd | Combination therapies for the treatment of cancer |
| EP4116291A4 (en) * | 2020-03-04 | 2024-03-06 | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | SYNTHESIS OF A NEW EP4 ANTAGONIST AND USE IN CANCER AND INFLAMMATION |
| TWI877433B (zh) * | 2020-11-30 | 2025-03-21 | 大陸商杭州阿諾生物醫藥科技有限公司 | 用於治療ｐｉｋ３ｃａ突變癌症的組合療法 |
| CN114790176A (zh) * | 2021-01-25 | 2022-07-26 | 武汉人福创新药物研发中心有限公司 | 咪唑类化合物及其制备方法和用途 |
| EP4286371A4 (en) * | 2021-01-28 | 2025-01-08 | Shenzhen Zhongge Biological Technology Co., Ltd. | Pyrazolamide derivative, preparation method therefor, and application thereof |
-
2022
- 2022-09-02 WO PCT/CN2022/116768 patent/WO2023030492A1/zh not_active Ceased
- 2022-09-02 JP JP2024513882A patent/JP7819298B2/ja active Active
- 2022-09-02 TW TW111133462A patent/TW202328073A/zh unknown
- 2022-09-02 US US18/687,190 patent/US20240368088A1/en active Pending
- 2022-09-02 CA CA3230557A patent/CA3230557A1/en active Pending
- 2022-09-02 CN CN202211074188.5A patent/CN115745892A/zh active Pending
- 2022-09-02 EP EP22863626.2A patent/EP4397654A4/en active Pending
- 2022-09-02 KR KR1020247007045A patent/KR102959367B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7536721B2 (ja) | キナーゼを修飾する１ｈ－ピロロ［２，３－ｂ］ピリジン誘導体の合成 | |
| EP2970123B1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| JP4638491B2 (ja) | シナカルセト塩酸塩結晶フォームｉの調製方法 | |
| US9550716B2 (en) | Process for treprostinil salt preparation | |
| JP2014524920A5 (enExample) | ||
| JP2016528210A (ja) | ５−ブロモ−２−（α−ヒドロキシペンチル）安息香酸ナトリウム塩の複数の異なる結晶型及びそれらの調製方法 | |
| JP2019504103A5 (enExample) | ||
| EP2817303A2 (en) | Solid forms of dabigatran etexilate mesylate and processes for their preparation | |
| JP2007505879A (ja) | 既知の抗高脂血症剤の多形体 | |
| JP2002530376A (ja) | 新規製造方法 | |
| JP2008524210A5 (enExample) | ||
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| CA3244893A1 (en) | PROCESS FOR PREPARING (5S)-{[2-(4-CARBOXYPHENYL)ETHYL] |2-(2-{|3-CHLORO-4'-(TRIFLUOROMETHYL)BIPHENYL-4-YL]METHOXY}PHENYL)ETHYL]AMINOL-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLIC AND ITS CRYSTALLINE FORMS FOR USE AS A PHARMACEUTICALLY ACTIVE COMPOUND | |
| CN107033094A (zh) | 一种药物共晶的晶型及其制备方法和组合物 | |
| JP2019500385A5 (enExample) | ||
| JP5264904B2 (ja) | スルファニル誘導体、及び合成中間体としてのその使用 | |
| CN107646037A (zh) | 选择性合成核苷氨基磷酸酯类化合物的方法 | |
| JP2007246396A (ja) | ５−ジフルオロメトキシ−４−チオメチルピラゾール化合物の製造方法 | |
| KR20180105450A (ko) | 피마살탄 콜린염 및 이의 수화물의 제조방법 | |
| CN106432253B (zh) | 一种维帕他韦新晶型及其制备方法 | |
| TWI825076B (zh) | 用於製備曲前列尼爾二乙醇胺鹽之多晶型ｂ的方法 | |
| EP3456726B1 (en) | Fosaprepitant phosphate intermediate and preparation method therefor | |
| JP2017514867A5 (enExample) | ||
| KR100957725B1 (ko) | 실라스타틴 중간체의 제조 방법 | |
| US11111208B2 (en) | Process for the preparation of safinamide mesylate intermediate |